Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4QIX0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0051213 | dioxygenase activity | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 17 | 21 | PF00656 | 0.636 |
CLV_NRD_NRD_1 | 243 | 245 | PF00675 | 0.238 |
CLV_NRD_NRD_1 | 319 | 321 | PF00675 | 0.707 |
CLV_PCSK_FUR_1 | 316 | 320 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 242 | 244 | PF00082 | 0.237 |
CLV_PCSK_KEX2_1 | 315 | 317 | PF00082 | 0.685 |
CLV_PCSK_KEX2_1 | 318 | 320 | PF00082 | 0.692 |
CLV_PCSK_PC1ET2_1 | 315 | 317 | PF00082 | 0.736 |
CLV_PCSK_PC1ET2_1 | 318 | 320 | PF00082 | 0.742 |
CLV_PCSK_SKI1_1 | 187 | 191 | PF00082 | 0.262 |
CLV_PCSK_SKI1_1 | 312 | 316 | PF00082 | 0.734 |
DOC_CKS1_1 | 227 | 232 | PF01111 | 0.448 |
DOC_CYCLIN_RxL_1 | 184 | 194 | PF00134 | 0.448 |
DOC_MAPK_FxFP_2 | 200 | 203 | PF00069 | 0.437 |
DOC_MAPK_gen_1 | 171 | 181 | PF00069 | 0.434 |
DOC_MAPK_MEF2A_6 | 174 | 183 | PF00069 | 0.437 |
DOC_PP1_RVXF_1 | 185 | 192 | PF00149 | 0.437 |
DOC_PP1_SILK_1 | 66 | 71 | PF00149 | 0.473 |
DOC_PP4_FxxP_1 | 119 | 122 | PF00568 | 0.416 |
DOC_PP4_FxxP_1 | 200 | 203 | PF00568 | 0.437 |
DOC_PP4_MxPP_1 | 293 | 296 | PF00568 | 0.570 |
DOC_SPAK_OSR1_1 | 234 | 238 | PF12202 | 0.437 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.462 |
DOC_USP7_MATH_1 | 296 | 300 | PF00917 | 0.661 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.545 |
DOC_WW_Pin1_4 | 226 | 231 | PF00397 | 0.458 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.535 |
LIG_14-3-3_CanoR_1 | 265 | 270 | PF00244 | 0.575 |
LIG_14-3-3_CanoR_1 | 87 | 93 | PF00244 | 0.543 |
LIG_BRCT_BRCA1_1 | 125 | 129 | PF00533 | 0.451 |
LIG_BRCT_BRCA1_1 | 187 | 191 | PF00533 | 0.462 |
LIG_deltaCOP1_diTrp_1 | 112 | 119 | PF00928 | 0.472 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.437 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.437 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.437 |
LIG_FHA_1 | 219 | 225 | PF00498 | 0.437 |
LIG_FHA_2 | 126 | 132 | PF00498 | 0.504 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.639 |
LIG_FHA_2 | 266 | 272 | PF00498 | 0.449 |
LIG_LIR_Apic_2 | 199 | 203 | PF02991 | 0.539 |
LIG_LIR_Gen_1 | 126 | 137 | PF02991 | 0.440 |
LIG_LIR_Gen_1 | 233 | 239 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 63 | 73 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 126 | 132 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 138 | 142 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 199 | 205 | PF02991 | 0.527 |
LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.436 |
LIG_LIR_Nem_3 | 37 | 41 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 63 | 68 | PF02991 | 0.368 |
LIG_SH2_CRK | 89 | 93 | PF00017 | 0.374 |
LIG_SH2_STAP1 | 145 | 149 | PF00017 | 0.447 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 75 | 78 | PF00017 | 0.315 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.663 |
LIG_SH3_3 | 224 | 230 | PF00018 | 0.423 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.674 |
MOD_CK1_1 | 123 | 129 | PF00069 | 0.404 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.388 |
MOD_CK2_1 | 125 | 131 | PF00069 | 0.554 |
MOD_Cter_Amidation | 240 | 243 | PF01082 | 0.237 |
MOD_DYRK1A_RPxSP_1 | 226 | 230 | PF00069 | 0.432 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.553 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.675 |
MOD_GlcNHglycan | 298 | 301 | PF01048 | 0.714 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.675 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.580 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.467 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.698 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.529 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.448 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.507 |
MOD_NEK2_2 | 34 | 39 | PF00069 | 0.382 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.417 |
MOD_PIKK_1 | 153 | 159 | PF00454 | 0.539 |
MOD_PIKK_1 | 193 | 199 | PF00454 | 0.539 |
MOD_PKA_2 | 233 | 239 | PF00069 | 0.441 |
MOD_Plk_1 | 175 | 181 | PF00069 | 0.437 |
MOD_Plk_1 | 63 | 69 | PF00069 | 0.520 |
MOD_Plk_4 | 215 | 221 | PF00069 | 0.388 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.463 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.430 |
MOD_ProDKin_1 | 226 | 232 | PF00069 | 0.458 |
MOD_SUMO_for_1 | 92 | 95 | PF00179 | 0.370 |
TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.448 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.355 |
TRG_ER_diArg_1 | 242 | 244 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 28 | 31 | PF00400 | 0.559 |
TRG_ER_diArg_1 | 319 | 321 | PF00400 | 0.625 |
TRG_NES_CRM1_1 | 131 | 143 | PF08389 | 0.452 |
TRG_NLS_MonoExtC_3 | 314 | 319 | PF00514 | 0.592 |
TRG_NLS_MonoExtN_4 | 312 | 319 | PF00514 | 0.592 |
TRG_Pf-PMV_PEXEL_1 | 171 | 175 | PF00026 | 0.257 |
TRG_Pf-PMV_PEXEL_1 | 244 | 248 | PF00026 | 0.280 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKD0 | Leptomonas seymouri | 74% | 87% |
A0A0S4JRX9 | Bodo saltans | 47% | 100% |
A0A1X0NKP4 | Trypanosomatidae | 65% | 100% |
A0A3R7KF49 | Trypanosoma rangeli | 58% | 95% |
A0A3S7WPM5 | Leishmania donovani | 94% | 100% |
A4H4R9 | Leishmania braziliensis | 82% | 100% |
A4HSZ8 | Leishmania infantum | 94% | 94% |
C9ZTN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 64% | 100% |
E9AKY5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 96% |
V5BXY4 | Trypanosoma cruzi | 58% | 100% |